Population
Tumours, EAG expressing cells, and in vivo mouse tumour models
Design
Review
Authors
Loading...
Hypothesis-generating for EAG as tumor marker and target; prospective trials needed before clinical adoption.
The potassium channel EAG is highly expressed in tumours and its inhibition reduces cell proliferation, highlighting its potential as a tumour marker and therapeutic target.
Stühmer et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: